Nantahala Capital Management - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 39 filers reported holding NEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$2,445,000
-22.6%
4,610,0000.0%0.08%
-21.1%
Q2 2020$3,158,000
-8.7%
4,610,0000.0%0.10%
-26.9%
Q1 2020$3,458,000
-50.3%
4,610,0000.0%0.13%
-39.3%
Q4 2019$6,961,000
+2.0%
4,610,0000.0%0.21%
-15.4%
Q3 2019$6,823,000
+14.7%
4,610,0000.0%0.25%
+38.3%
Q2 2019$5,947,000
-49.2%
4,610,000
+2.8%
0.18%
-49.9%
Q1 2019$11,706,000
+58.2%
4,485,0000.0%0.36%
+60.1%
Q4 2018$7,400,0004,485,0000.23%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DSC Advisors, L.P. 784,704$5,163,0003.14%
WALL STREET ASSOCIATES 149,343$983,0000.34%
DAFNA Capital Management LLC 38,873$256,0000.18%
Perceptive Advisors 330,593$2,175,0000.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 229,166$1,508,0000.07%
FALCON POINT CAPITAL, LLC 69,135$408,0000.06%
Cormorant Asset Management, LP 50,613$333,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 80,000$526,0000.01%
FRANKLIN RESOURCES INC 1,314,700$8,650,0000.01%
PUTNAM INVESTMENTS LLC 215,000$1,415,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders